| Symbol |
Name |
|
AASTH42
|
Allergic/atopic asthma related QTL 42
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCG5
|
ATP-binding cassette, sub-family G (WHITE), member 5
|
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ACVR1C
|
activin A receptor, type IC
|
|
ADA
|
adenosine deaminase
|
|
ADCY5
|
adenylate cyclase 5
|
|
ADCY8
|
adenylate cyclase 8 (brain)
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
AMER1
|
APC membrane recruitment protein 1
|
|
AMH
|
anti-Mullerian hormone
|
|
APC
|
adenomatous polyposis coli
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
AQP4
|
aquaporin 4
|
|
ARX
|
aristaless related homeobox
|
|
ASTN2
|
astrotactin 2
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
|
AVP
|
arginine vasopressin
|
|
AVPR1B
|
arginine vasopressin receptor 1B
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
CASK
|
calcium/calmodulin-dependent serine protein kinase (MAGUK family)
|
|
CASP12
|
caspase 12 (gene/pseudogene)
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CD14
|
CD14 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD52
|
CD52 molecule
|
|
CDKAL1
|
CDK5 regulatory subunit associated protein 1-like 1
|
|
CDKL5
|
cyclin-dependent kinase-like 5
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CLEC4M
|
C-type lectin domain family 4, member M
|
|
CLOCK
|
clock circadian regulator
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COL12A1
|
collagen, type XII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COL4A4
|
collagen, type IV, alpha 4
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COMT
|
catechol-O-methyltransferase
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP46A1
|
cytochrome P450, family 46, subfamily A, polypeptide 1
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIO1
|
deiodinase, iodothyronine, type I
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKC1
|
dyskeratosis congenita 1, dyskerin
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
EDA
|
ectodysplasin A
|
|
EDNRA
|
endothelin receptor type A
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2B5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
|
|
ENOX2
|
ecto-NOX disulfide-thiol exchanger 2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESYT3
|
extended synaptotagmin-like protein 3
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FASN
|
fatty acid synthase
|
|
FHIT
|
fragile histidine triad
|
|
FLNA
|
filamin A, alpha
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXP3
|
forkhead box P3
|
|
FRMD7
|
FERM domain containing 7
|
|
FRZB
|
frizzled-related protein
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FTO
|
fat mass and obesity associated
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GAL3ST1
|
galactose-3-O-sulfotransferase 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLA
|
galactosidase, alpha
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GPR50
|
G protein-coupled receptor 50
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRIA3
|
glutamate receptor, ionotropic, AMPA 3
|
|
GRIA4
|
glutamate receptor, ionotropic, AMPA 4
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HERC2
|
HECT and RLD domain containing E3 ubiquitin protein ligase 2
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMOX1
|
heme oxygenase 1
|
|
HOXB9
|
homeobox B9
|
|
HOXD9
|
homeobox D9
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTT
|
huntingtin
|
|
IDE
|
insulin-degrading enzyme
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IL10
|
interleukin 10
|
|
IL1B
|
interleukin 1, beta
|
|
IL23R
|
interleukin 23 receptor
|
|
IL33R
|
interleukin 33 receptor
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
INHBB
|
inhibin, beta B
|
|
INS
|
insulin
|
|
INSIG2
|
insulin induced gene 2
|
|
INSR
|
insulin receptor
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
JAK2
|
Janus kinase 2
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LCT
|
lactase
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LIPE
|
lipase, hormone-sensitive
|
|
LMTK3
|
lemur tyrosine kinase 3
|
|
LPL
|
lipoprotein lipase
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA
|
lymphotoxin alpha
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MARVELD1
|
MARVEL domain containing 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR146A
|
microRNA 146a
|
|
MIR518D
|
microRNA 518d
|
|
MLH1
|
mutL homolog 1
|
|
MMP11
|
matrix metallopeptidase 11
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPO
|
myeloperoxidase
|
|
MRC1
|
mannose receptor, C type 1
|
|
MSH2
|
mutS homolog 2
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MYT1L
|
myelin transcription factor 1-like
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NDP
|
Norrie disease (pseudoglioma)
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NHS
|
Nance-Horan syndrome (congenital cataracts and dental anomalies)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NPPB
|
natriuretic peptide B
|
|
NPPC
|
natriuretic peptide C
|
|
NPY
|
neuropeptide Y
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NTSR1
|
neurotensin receptor 1 (high affinity)
|
|
OCA2
|
oculocutaneous albinism II
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OXTR
|
oxytocin receptor
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PCDH19
|
protocadherin 19
|
|
PDCD1
|
programmed cell death 1
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDYN
|
prodynorphin
|
|
PGM1
|
phosphoglucomutase 1
|
|
PHF6
|
PHD finger protein 6
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLS3
|
plastin 3
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
POU3F4
|
POU class 3 homeobox 4
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
PSCA
|
prostate stem cell antigen
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRR
|
protein tyrosine phosphatase, receptor type, R
|
|
PYY
|
peptide YY
|
|
RALBP1
|
ralA binding protein 1
|
|
RAPGEF6
|
Rap guanine nucleotide exchange factor (GEF) 6
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RGCC
|
regulator of cell cycle
|
|
RNF212
|
ring finger protein 212
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RS1
|
retinoschisin 1
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SCAP
|
SREBF chaperone
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SELE
|
selectin E
|
|
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SHOX
|
short stature homeobox
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC45A2
|
solute carrier family 45, member 2
|
|
SLC45A3
|
solute carrier family 45, member 3
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC6A8
|
solute carrier family 6 (neurotransmitter transporter), member 8
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOST
|
sclerostin
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SP1
|
Sp1 transcription factor
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
STAR
|
steroidogenic acute regulatory protein
|
|
STEAP4
|
STEAP family member 4
|
|
STK11
|
serine/threonine kinase 11
|
|
SULT1E1
|
sulfotransferase family 1E, estrogen-preferring, member 1
|
|
TAS2R38
|
taste receptor, type 2, member 38
|
|
TBC1D22A
|
TBC1 domain family, member 22A
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TIMELESS
|
timeless circadian clock
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR6
|
toll-like receptor 6
|
|
TLR7
|
toll-like receptor 7
|
|
TMEM43
|
transmembrane protein 43
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TRB
|
T cell receptor beta locus
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TUBB6
|
tubulin, beta 6 class V
|
|
TYMS
|
thymidylate synthetase
|
|
TYR
|
tyrosinase
|
|
UBQLN2
|
ubiquilin 2
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6
|
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15
|
|
USF1
|
upstream transcription factor 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIMP
|
VCP-interacting membrane selenoprotein
|
|
VIPR1
|
vasoactive intestinal peptide receptor 1
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WT1
|
Wilms tumor 1
|
|
XIST
|
X inactive specific transcript (non-protein coding)
|
|
XPNPEP2
|
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
